RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:CAR macrophages tuning the immune symphony of anti-cancer therapies.
CAR macrophages tuning the immune symphony of anti-cancer therapies.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)巨噬细胞拓宽了抗癌免疫治疗的版图,以对抗实体恶性肿瘤。Shah等人引入CAR以促进CAR巨噬细胞疗法,该疗法旨在招募并激活T/NK 细胞,进一步加强整体免疫反应,以减轻胰腺癌负荷和转移扩散。
Chimeric antigen receptor (CAR) macrophages have broadened the landscape of anti-cancer immunotherapies to combat solid malignancies. Shah et al. introduce CARs to facilitate a CAR macrophage therapy, which aims to recruit and activate T/natural killer cells, further strengthening the overall immune response to decrease pancreatic cancer burden and metastatic spreading.
MEMBER ACCOUNT
登录成功会直接打开下一页。